The Unit of Biomarkers and Susceptibility is part of the Cancer Prevention and Control Program at the Catalan Institute of Oncology (ICO). It is a research group working in the area of discovery and validation of molecular biomarkers in cancer, with interest in diagnosis, prognosis and response to treatment. The Unit also collaborates with other research groups of the institution in projects related to cancer biomarkers.

Its research is focused on genetic epidemiology, molecular diagnosis of cancer, markers in the prognosis and predicting therapeutic response and the identification of new therapeutic targets.

Read more